Pharma Innovation And NHS Dodge Axe In U.K. Spending Review, But There Is A Price To Pay
This article was originally published in The Pink Sheet Daily
Executive Summary
Science R&D spending will be maintained at current levels but amount to be allocated for pharmaceuticals unclear.